scispace - formally typeset
S

Sheng Peng

Researcher at Brown University

Publications -  20
Citations -  4541

Sheng Peng is an academic researcher from Brown University. The author has contributed to research in topics: Nanoparticle & Magnetic nanoparticles. The author has an hindex of 16, co-authored 20 publications receiving 4224 citations.

Papers
More filters
Journal ArticleDOI

Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage

TL;DR: This tutorial review summarizes the recent advances in the chemical synthesis and potential applications of monodisperse magnetic nanoparticles and outlines the surface, structural, and magnetic properties of these nanoparticles for biomedicine and magnetic energy storage applications.
Journal ArticleDOI

Synthesis and Stabilization of Monodisperse Fe Nanoparticles

TL;DR: Monodisperse Fe nanoparticles are synthesized via a simple one-pot thermal decomposition of Fe(CO)5 in the presence of oleylamine and are suitable for biomolecule attachment and biomedical applications.
Journal ArticleDOI

Porous Hollow Fe3O4 Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin

TL;DR: Low pH-responsive PHNPs of Fe(3)O(4) can be exploited as a cisplatin delivery vehicle for target-specific therapeutic applications, and is reported to be able to target to breast cancer SK-BR-3 cells with IC(50) reaching 2.9 muM, much lower than 6.8 muM needed for free cisPlatin.
Journal ArticleDOI

Multimetallic Au/FePt3 nanoparticles as highly durable electrocatalyst.

TL;DR: The design and synthesis of multimetallic Au/Pt-bimetallic nanoparticles are reported as a highly durable electrocatalyst for the oxygen reduction reaction (ORR) in proton exchange membrane fuel cells with mass-activity enhancement of more than 1 order of magnitude over Pt catalysts.
Journal ArticleDOI

Ultrasmall c(RGDyK)-Coated Fe3O4 Nanoparticles and Their Specific Targeting to Integrin αvβ3-Rich Tumor Cells

TL;DR: These c(RGDyK)-MC-Fe3O4 NPs accumulate preferentially in the integrin alphavbeta3-rich tumor area, which is readily tracked by MRI.